Get the Stockscreener App
17.20
1.09%
-0.19
Pre-market:
12.90
-4.30
-25.00%
Biohaven Ltd stock is traded at $17.20, with a volume of 2.43M.
It is down -1.09% in the last 24 hours and up +14.59% over the past month.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
See More
Previous Close:
$17.39
Open:
$17.2
24h Volume:
2.43M
Relative Volume:
1.09
Market Cap:
$1.82B
Revenue:
-
Net Income/Loss:
$-766.97M
P/E Ratio:
-2.2454
EPS:
-7.66
Net Cash Flow:
$-646.43M
1W Performance:
+3.61%
1M Performance:
+14.59%
6M Performance:
-22.24%
1Y Performance:
-65.43%
1-Day Range:
$16.90
$17.84
1-Week Range:
$16.80
$18.57
52-Week Range:
$12.79
$54.98
Biohaven Ltd Stock (BHVN) Company Profile
Name
Biohaven Ltd
Sector
Industry
Phone
203-404-0410
Address
215 CHURCH STREET, NEW HAVEN, CT
Compare BHVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
17.20 | 1.84B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Initiated | Citigroup | Buy |
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-19-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Sep-16-24 | Initiated | Jefferies | Buy |
| Sep-04-24 | Initiated | Bernstein | Outperform |
| Jul-24-24 | Initiated | Morgan Stanley | Overweight |
| Feb-16-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Dec-22-23 | Initiated | H.C. Wainwright | Buy |
| Dec-08-23 | Initiated | Robert W. Baird | Outperform |
| Jan-24-23 | Initiated | SVB Securities | Outperform |
| Jan-04-23 | Initiated | JP Morgan | Overweight |
| Dec-02-22 | Initiated | BTIG Research | Buy |
| Oct-26-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-12-22 | Initiated | Piper Sandler | Overweight |
| Aug-19-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-08-22 | Downgrade | Wedbush | Outperform → Neutral |
| May-11-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Oct-19-21 | Resumed | Morgan Stanley | Equal-Weight |
| Aug-10-21 | Downgrade | UBS | Buy → Neutral |
| Aug-03-21 | Reiterated | Canaccord Genuity | Buy |
| Mar-11-21 | Initiated | UBS | Buy |
| Dec-15-20 | Initiated | H.C. Wainwright | Buy |
| Apr-17-20 | Initiated | Cowen | Outperform |
| Feb-10-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Nov-22-19 | Initiated | Wedbush | Outperform |
| Jun-25-19 | Reiterated | Canaccord Genuity | Buy |
| May-06-19 | Initiated | Goldman | Buy |
| Apr-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-04-19 | Reiterated | Needham | Buy |
| Jul-03-18 | Reiterated | Needham | Buy |
| Jul-02-18 | Reiterated | Needham | Buy |
| Apr-05-18 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-22-18 | Reiterated | Canaccord Genuity | Buy |
| Dec-15-17 | Initiated | Canaccord Genuity | Buy |
| Oct-03-17 | Reiterated | Needham | Buy |
View All
Biohaven Ltd Stock (BHVN) Latest News
Is a relief rally coming for Biohaven Ltd. holdersWeekly Investment Report & Technical Confirmation Alerts - newser.com
Has Biohaven Ltd. formed a bullish divergenceWeekly Trend Report & Community Trade Idea Sharing Platform - newser.com
Will Biohaven Ltd. stock gain from government policiesPortfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Predicting Biohaven Ltd. trend using moving averages2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
How cyclical is Biohaven Ltd. Common Shares stock compared to rivalsJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Biohaven Ltd. (NYSE:BHVN) institutional owners may be pleased with recent gains after 66% loss over the past year - Yahoo Finance
How Biohaven Ltd. Common Shares stock trades in high volatilityTrend Reversal & AI Forecast Swing Trade Picks - newser.com
Earnings visualization tools for Biohaven Ltd.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Biohaven Ltd. stock chart pattern explainedQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Relative strength of Biohaven Ltd. in sector analysisJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Is Biohaven Ltd. Common Shares stock a contrarian opportunityJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Will Biohaven Ltd. stock remain a Wall Street favoriteEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Will Biohaven Ltd. stock maintain momentum in 20252025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Market reaction to Biohaven Ltd.’s recent newsJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
Biohaven Ltd. stock trend outlook and recovery pathPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Emerald Mutual Fund Advisers Trust Has $2.44 Million Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Emerald Advisers LLC Sells 33,944 Shares of Biohaven Ltd. $BHVN - MarketBeat
Signal strength of Biohaven Ltd. stock in tech scannersTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Why retail investors pile into Biohaven Ltd. stockTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Vanguard holds 2,875,190 Biohaven shares; 2.71% of class - Stock Titan
Biohaven Ltd. $BHVN Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Will Biohaven Ltd. stock gain from strong economyJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Biohaven Ltd Stock (BHVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):